|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians
Zomedica (NYSE American: ZOM) announced that the United States Equestrian Federation (USEF) has designated PulseVet® as the Official Shock Wave Therapy Supplier for the US Equestrian team veterinarians. PulseVet's advanced electro-hydraulic shock wave technology, renowned for treating equine injuries and enhancing performance, will support US equine athletes ahead of major international competitions, including the Olympics. This collaboration underscores both organizations' commitment to equine welfare and excellence.
|
|
|
|
Sharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024
Sharps Technology (Nasdaq: STSS) an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, encourages its shareholders to vote on key proposals at the special meeting on July 15, 2024. Votes must be cast by July 12, 2024. The Board of Directors emphasizes the importance of this shareholders’ vote, specifically so that the Company can achieve its goal of passing the three proposals as listed and explained in the Company’s definitive proxy statement filed on June 26, 2024. Shareholders of record as of May 17, 2024, can vote online or by phone.
|
|
|
|
|
Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap
Annovis Bio INYSE American: ANVS) unveiled new Phase III data demonstrating that its drug, Buntanetap, significantly improves motor and cognitive functions in Parkinson's Disease (PD) patients. Buntanetap showed dose-dependent cognitive benefits, particularly in patients with substantial cognitive decline, and improved Unified Parkinson's Disease Rating Scale (MDS-UPDRS) scores in those diagnosed for over three years and those with postural instability and gait difficulties. The drug met all primary and secondary endpoints, reinforcing its potential as a transformative therapy for neurodegenerative diseases.
|
|
|
|
|
|
|
Additional Orders received for Mobilicom’s Cybersecure Drone Data Link System from One of the Largest U.S.-based Drone Manufacturers — Market Expected to Reach $18 Billion by 2030, Growing at an Annual Compound Rate of 25%
Mobilicom (Nasdaq: MOB) received a follow-on order for its SkyHopper PRO cybersecure drone data link system from a leading U.S. drone manufacturer. This defense manufacturer, with over $5 billion in annual sales, selected SkyHopper PRO for its robust, secure performance and superior size, weight, power, and cost efficiency. The $500,000 order is part of a growing trend, with the global drone data link market projected to reach $18 billion by 2030. Mobilicom anticipates further orders as the demand for uncrewed autonomous vehicles continues to rise.
|
|
|
|
|
Can-Fite Reports Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson
Can-Fite BioPharma (NYSE American: CANF) announced encouraging results from a compassionate use treatment with Namodenoson for a patient with decompensated liver cirrhosis at Soroka Medical Center, Israel. The 63-year-old patient showed significant improvement in liver function tests and has not experienced decompensation events since starting the treatment. Namodenoson, currently in Phase III trials for advanced liver cancer and Phase IIb for MASH, demonstrated liver protective effects and a favorable safety profile. The liver cirrhosis treatment market is projected to reach $29.2 billion by 2030, highlighting the need for effective therapies.
|
|
|
|
|
|
Small Stocks, Big Money™ Podcast
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
|
|
|
|
Upcoming Events
|
|
|
NASDAQ: LOBO - LOBO EV
4:15pm Eastern
LOBO EV, headquartered in Wuxi, China, is a pioneering OEM and ODM manufacturer and seller of electric vehicles (EVs), including e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles, tailored for various demographics, including mobility solutions for the elderly and disabled.
|
|
|
|
NASDAQ: NTRB - Nutriband Inc.
4:15pm Eastern
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
|
|
|
|
Archived Events
|
|
|
NASDAQ: GENE - Genetic Technologies Limited
4:15pm Eastern
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health.
|
|
|
|
NASDAQ: BIVI - BioVie Inc.
4:15pm Eastern
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease.
|
|
|
|
NASDAQ: ENLV- Enlivex Therapeutics
4:15pm Eastern
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses.
|
|
|
|
Quote of the Week
|
"I'd be a bum on the street with a tin cup if the markets were efficient."
|
|
|
|
|
RedChip TV
|
|
|
|
RedChip TV Highlights BioVie (NASDAQ: BIVI) & Bioaffinity Technologies (NASDAQ:BIAF)
|
|
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
Humility plays a vital role in market forecasting.
|
|
|
|
|
|
MidSouth Week in Review
The S&P and the NASDAQ both noticed records as the inflation gauge declined to mostly bets that the Federal Reserve will cut rates this year.
|
|
|
|
|
|
|
|
